{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:02:45Z","timestamp":1791442965782,"version":"4.3.3"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"DOI":"10.1093\/schbul\/sbaf256","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:55:48Z","timestamp":1766494548000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparing Apples to Oranges Obscures Tortoises Beating Hares: The Relationship Between Rate of Antipsychotic Tapering and Relapse"],"prefix":"10.1093","volume":"52","author":[{"given":"Mark Abie","family":"Horowitz","sequence":"first","affiliation":[{"name":"Research and Development Department, North East London NHS Foundation Trust (NELFT) , 157 Barley Lane, Goodmayes, IG3 8XJ, Ilford ,","place":["United Kingdom"]},{"name":"Institute of Pharmaceutical Sciences King\u2019s College London , Franklin-Wilkins Building, 150 Stamford Street, SE1 9NH, London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"key":"2026061410260743500_ref1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/schbul\/sbad139","article-title":"Does slow and steady win the race? Rates of antipsychotic discontinuation, antipsychotic dose, and risk of psychotic relapse","volume":"50","author":"McCutcheon","year":"2023","journal-title":"Schizophr Bull"},{"key":"2026061410260743500_ref2","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1176\/appi.ajp.2010.09060880","article-title":"Illness risk following rapid versus gradual discontinuation of antidepressants","volume":"167","author":"Baldessarini","year":"2010","journal-title":"Am J Psychiatry"},{"key":"2026061410260743500_ref3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1034\/j.1399-5618.1999.10106.x","article-title":"Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications","volume":"1","author":"Baldessarini","year":"1999","journal-title":"Bipolar Disord"},{"key":"2026061410260743500_ref4","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgaa002","article-title":"Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia: a systematic review and meta-analysis","volume":"1","author":"Bogers","year":"2020","journal-title":"Schizophr Bull Open"},{"key":"2026061410260743500_ref5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/schbul\/sbac138","article-title":"Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia. a meta-analysis of randomized controlled trials","volume":"49","author":"Bogers","year":"2023","journal-title":"Schizophr Bull"},{"key":"2026061410260743500_ref6","journal-title":"Schizophr. Bull"},{"key":"2026061410260743500_ref7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S2215-0366(22)00014-1","article-title":"Adverse events after antipsychotic discontinuation: an individual participant data meta-analysis","volume":"9","author":"Brandt","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"2026061410260743500_ref8","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000940","article-title":"Gradually tapering off antipsychotics: lessons for practice from case studies and neurobiological principles","volume":"37","author":"Horowitz","journal-title":"Curr Opin Psychiatry"},{"key":"2026061410260743500_ref9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/schbul\/sbab146","article-title":"Confounding of antipsychotic discontinuation studies by withdrawal-related relapse","volume":"48","author":"Horowitz","year":"2022","journal-title":"Schizophr Bull"},{"key":"2026061410260743500_ref10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/schbul\/sbab017","article-title":"A method for tapering antipsychotic treatment that may minimize the risk of relapse","volume":"47","author":"Horowitz","year":"2021","journal-title":"Schizophr Bull"},{"key":"2026061410260743500_ref11","doi-asserted-by":"publisher","first-page":"20451253231198464","DOI":"10.1177\/20451253231198463","article-title":"Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an in silico modelling study","volume":"13","author":"O\u2019Neill","year":"2023","journal-title":"Ther Adv Psychopharmacol"},{"key":"2026061410260743500_ref12","doi-asserted-by":"publisher","first-page":"20451253241272790","DOI":"10.1177\/20451253241272790","article-title":"Using in silico methods to determine optimal tapering regimens for decanoate-based long-acting injectable psychosis drugs","volume":"14","author":"O\u2019Neill","year":"2024","journal-title":"Ther Adv Psychopharmacol"},{"key":"2026061410260743500_ref13","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"2026061410260743500_ref14","volume":"72","journal-title":"JAMA Psychiatry"},{"key":"2026061410260743500_ref15","volume":"76","journal-title":"J. Clin. Psychiatry"},{"key":"2026061410260743500_ref16","volume":"116","journal-title":"Schizophr. Res"},{"key":"2026061410260743500_ref17","volume":"27","journal-title":"J. Clin. Psychopharmacol"},{"key":"2026061410260743500_ref18","volume":"53","journal-title":"Biol. Psychiatry"},{"key":"2026061410260743500_ref19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/00004714-199004000-00027","article-title":"Delayed onset of neuroleptic malignant syndrome after discontinuation of thioridazine","volume":"10","author":"Kasckow","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"2026061410260743500_ref20","author":"NICE","year":"2022"},{"key":"2026061410260743500_ref21","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/jamapsychiatry.2021.2130","article-title":"Examination of dosing of antipsychotic drugs for relapse prevention in patients with stable schizophrenia: a meta-analysis","volume":"78","author":"Leucht","year":"2021","journal-title":"JAMA Psychiatry"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/3\/sbaf256\/68523284\/sbaf256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/3\/sbaf256\/68523284\/sbaf256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:10:12Z","timestamp":1781453412000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/doi\/10.1093\/schbul\/sbaf256\/8707717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6,14]]},"published-print":{"date-parts":[[2026,4,10]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbaf256","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,10]]},"article-number":"sbaf256"}}